How NASA selects when to launch for the Moon

NASA announced 16 launch windows between February and April for Artemis II, the first crewed flight in the Artemis program, carrying a four-person crew including Christina Koch with a combined ~700 days in space. The 10-day mission will validate the Orion spacecraft and systems, travel roughly 4,700 miles beyond the Moon’s far side, and relies on two-hour daily windows timed by moonrise and lunar phase (windows shift ~40 minutes later each day) to accommodate orbital mechanics, range conflicts and cryogenic propellant management. Rollout of the ~11-million-pound stack to Launch Complex 39B and the constrained schedule will drive operations for launch-service providers, range logistics and ground-support suppliers.

Analysis

Market structure: Successful Artemis II launch disproportionately benefits large defense/aerospace primes and mid‑cap propulsion/systems suppliers (Lockheed Martin LMT, Northrop Grumman NOC, Aerojet Rocketdyne AJRD, Boeing BA) via milestone payments, follow‑on Orion/SLS work and spares demand; Cape Canaveral range operators and cryogenic services see higher utilization and recurring revenue. Commercial launch competitors (private SpaceX/Blue Origin) gain little direct revenue from NASA’s crew mission but face increased competition for range/time slots; small launchers without government ties are relative losers.

Risk assessment: Immediate risk (days) is operational — scrub/failure will spike equity/credit volatility and can erase near‑term gains; short‑term (weeks–months) budget/contracting announcements from NASA/Congress (watch FY2026 appropriations timeline) can amplify moves ±10–20% in suppliers. Tail risks include a high‑profile failure triggering program review and multi‑year schedule slippage or export/regulatory action that delays international payloads; hidden dependencies include cryogenic boil‑off logistics and milestone‑tied cashflows for mid‑caps.

Trade implications: Use concentrated event windows (Feb–Apr 2026) to trade volatility: buy-call spreads on AJRD and 60‑day call spreads on LMT ahead of April windows; overweight aerospace & defense sector by 1–2% of portfolio for 6–18 months to capture program follow‑ons. Cross‑asset: expect modest safe‑haven flows into Treasuries on failure (5–10bp bias) and a short, sharp widening of high‑yield aerospace credits by 30–100bp.

Contrarian angles: Consensus understates recurring services/ground operations revenue (cryogenics, range ops, training) which accrues to niche contractors — prefer select mid‑caps over already‑priced primes. Market may overreact to a single scrub; use option structures to harvest volatility rather than outright directional bets, and focus on milestone‑linked entry/exit tied to NASA announcements (rollout, T‑0 date, successful translunar injection).

Key Decisions for Investors

• Establish a 1.5–2.0% long position in Lockheed Martin (LMT) targeting +12–18% upside over 12 months; trim or re-evaluate if shares rise >20% or if NASA delays Artemis II beyond April 2026.
• Initiate a 1.0–1.5% tactical long in Aerojet Rocketdyne (AJRD) as a high‑beta supplier; preferred trade is a 60‑day ATM call spread entered 4–6 weeks before April launch windows (buy ATM, sell +15% strike) sized to risk 0.5–1.0% portfolio loss; target +20–30% nominal move on successful mission confirmation.
• Pair trade: Go long Northrop Grumman (NOC) 1.0% and short Boeing (BA) 0.75% (dollar‑neutral) for a 6–12 month horizon to capture relative operational execution risk in BA versus NOC exposure to government programs; close if spread moves >10% against position.
• Volatility play: Allocate 0.5–1.0% notional to buying short‑dated (10–14 day) straddles on AJRD ahead of each major launch window (Feb 6–11, Mar 6–11, Apr 1–6); sell into post‑launch vol collapse or on confirmation of translunar injection to capture event IV premium.